ThePigSite.com - news, features, articles and disease information for the swine industry

News

New Vaccine Developed for PED Virus

25 August 2016

CANADA - Scientists at the University of Saskatchewan (U of S) have developed and tested a prototype vaccine for Porcine Epidemic Diarrhea (PED) Virus.

The Porcine Epidemic Diarrhea Virus (PEDV) hit the United States in 2013 and spread to Canada in 2014. It was first discovered in Europe, and has become increasingly problematic in Asian countries. Occurring only in pigs, PEDV can kill up to 100 per cent of infected piglets.

PEDV is a coronavirus, a virus group which includes important emerging human diseases such as SARS and MERS.

Using its new containment Level 3 facility, the U of S Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) launched a vaccine development project.

“Our new facility, InterVac, provided us with the containment infrastructure to develop a vaccine and demonstrate it protected up to 100 per cent of the piglets,” said Dr Volker Gerdts, VIDO-InterVac’s research director.

The successful vaccine results triggered the interest of several animal health companies including Huvepharma, which has partnered with VIDO-InterVac to develop the technology for commercial production in North America.

“This is an exciting partnership with a world-class organization,” said Dr. Boris Gavrilov, senior scientist for biologics development at Huvepharma. “Our goal is to have the vaccine available for commercial use as soon as possible to help stop producer losses.”

With the support of the swine industry, the vaccine is now undergoing field testing in Saskatchewan, as well as in Manitoba where it is being used to help protect piglets from a recent PEDV outbreak.

ThePigSite News Desk

Top image via Shutterstock



Share This

News By

Related News

More News

China Pork Market

News from China   21 September 2016

Our Sponsors

Partners


Seasonal Picks

The Commuter Pig Keeper - 5m Books